Keratins as Susceptibility Genes for End-Stage Liver Disease
Background & Aims: Keratins 8 and 18 protect the liver from stress. Keratin 8 and 18 variants in 17 of 467 liver disease explants and 2 of 349 blood bank controls were previously reported in 5 analyzed exonic regions. We asked whether mutations were present in the remaining 10 exons of keratins 8 and 18. Methods: Exonic regions were polymerase chain reaction–amplified from genomic DNA, isolated from the above-mentioned 2 cohorts, and analyzed for the presence of mutations. Mutant keratins were also studied biochemically. Results: We identified 10 novel keratin 8 and 18 heterozygous variants in 44 of 467 explants and 11 of 349 controls: keratin 18 deletion (Δ64–71), a keratin 8 frameshift that truncates the last 14 amino acids; 8 missense keratin 8 and 18 alterations; and several new polymorphisms. The most common variant, keratin 8 R340H, at the highly conserved R340 was found in 30 of 467 explants and 10 of 349 controls (P = .02) and was confirmed in the diseased livers by generation of an R340H-specific antibody. Germline transmission and variant protein expression were verified. The mutations involved a variety of liver diseases, and some variants had an ethnic background preponderance. Mutations that introduced disulfide bonds (keratin 8 G61C or R453C) decreased keratin solubility, particularly after oxidative stress, whereas others decreased keratin 8 phosphorylation (keratin 8 G433S). Conclusions: The overall frequency of keratin 8 and 18 variants was 12.4% in 467 liver disease explants and 3.7% in 349 blood bank controls (P < .0001). Variants can alter keratin solubility or phosphorylation and may render individuals susceptible to end-stage liver disease, depending on their genetic background and exposure to other insults, such as alcohol or viral infection.
Abbreviations used in this paper: CI, confidence interval , K, keratin , MAPK, mitogen-activated protein kinase , OR, odds ratio , SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis , WT, wild type
To access this article, please choose from the options below
Supported by VA Merit and National Institutes of Health (NIH) grant DK47918 awards (to M.B.O.), and NIH Digestive Disease Center grant DK56339. N.-O.K. is supported in part by a Veterans Administration Research Enhancement Award Program, and NIH DK56339 Pilot Award.
PII: S0016-5085(05)01353-3
doi:10.1053/j.gastro.2005.06.065
© 2005 American Gastroenterological Association. Published by Elsevier Inc. All rights reserved.

